Care Coordination in Oncology, Quality Among Patients With Lung Cancer and Their Caregivers

The case-matched controlled design, exploratory evaluation study will look at how exposure to
a care coordination tool impacts quality and performance indicators associated with oncology
care from the perspective of patients, caregivers, and providers.

Geisinger research staff will recruit lung cancer patients and their caregivers across three
Geisinger locations: Geisinger Medical Center (GMC), Geisinger Wyoming Valley Medical Center
(GWV) and Geisinger Community Medical Center (GCMC). GMC will serve as the intervention site
and GWV and GCMC as control sites.

Eligible participants will be identified by the study staff through the electronic health
record as well as through clinical staff and approached in the oncology clinic as part of a
schedule office visit and/or treatment. For the purpose of study awareness, informational
flyers will be available to patients in the exam rooms, waiting rooms, and through Oncology
Care's Multi-Disciplinary clinic. Participants will asked to identify a caregiver who will
participate in the study as well, however this is not required.

Case dyads enrolled at the intervention site (GMC) will be asked to complete a survey when
they join the study and at the end of the study. Participants will also be asked to enroll in
the care coordination tool, a health information solution that integrates the patient,
caregiver, and clinical data to enhance communication and improve quality of care and
performance outcomes. Patients will also be asked to give permission to the study team to
access their health information via the e electronic health record. Participants will be in
the research study for about 8-10 weeks.

Control dyads enrolled at the control site (GWV and GCMC) will be asked to complete a survey
eight weeks after consenting to participate. Patients will be asked to give permission to the
study team to access their health information via the electronic health record. Participants
will be in the research study for about 8-10 weeks.

The study will also enroll oncology care providers within the Medical Oncology or Radiation
Oncology departments at GMC and who have patients enrolled in the study. Providers will be
asked to participate in a 30-minute interview to get their feedback and insights on the care
coordination tool.

Inclusion Criteria:

Patients:

- Patients who are 18 years of age or older and diagnosed with lung cancer who 1) are
scheduled to start Oncology Care (chemo and/or radiation-therapies) OR 2) on active
Oncology Care and recently started within 3 weeks (<27 days for experimental arm; <56
days control arm)

- Receive care at GMC, GWV, or GCMC

- English-speaking

- Established/intends to establish a MyGeisinger Account (cases only)

Caregivers:

- Recognized/intends to be recognized as proxy for patient's MyGeisinger Account (cases
only)

- English-speaking

Providers:

- Any health care provider within Medical Oncology or Radiation Oncology at GMC, where care
coordination tool is standard of care, who has a patient enrolled.

Exclusion Criteria:

Patients:

- Patients who are not diagnosed with lung cancer.

- Patients who are diagnosed with lung cancer and are on active Oncology Care exceeding
3 weeks (>27 days experimental arm; >56 days control arm).

Providers:

- Any healthcare provider not within the Medical Oncology or Radiation Oncology
departments.

- Any healthcare provider within Medical Oncology or Radiation Oncology who does not
have a patient enrolled (Case Dyad).